Imagine spending months and a six-figure budget on a supplement launch, only to watch a competitor’s bottle outsell yours because of three words on the label: “clinically proven results.” That gap between a good product and a proven one is often what decides who wins the shelf. Supplements do not need FDA approval before they […]
Human clinical trials are supposed to answer one simple question: does this treatment work, and is it safe? But the first time a new drug is given to a person, known as a first in human study, is where many biotech programs quietly go wrong. The problem is rarely bad luck. It is usually study […]
Introduction The oncology landscape is undergoing a remarkable transformation. Advances in precision medicine, immunotherapy, cell and gene therapies, antibody-drug conjugates (ADCs), and targeted therapies are redefining how cancer is diagnosed, treated, and monitored. These emerging oncology modalities are enabling more personalized treatment approaches, improving patient outcomes, and accelerating the development of innovative therapeutics. Behind these […]
Most articles on choosing a CRO partner tell you the same thing. Look for experience. Check regulatory expertise. Ask about quality systems. This advice is not necessarily wrong, but it is not very useful either. Almost every CRO company will claim to tick these boxes on their website. The real problem is different. Sponsors usually know what to look for. What they don’t have […]
Most biotechs write their protocol first. Then they bring in a CRO to help with submissions and operations. It feels like the natural order. Design the science, then handle the paperwork. This order is usually a mistake. By the time a CRO gets involved, the big decisions are already locked in. Endpoints are chosen. The dose escalation […]
If your pharma company is planning its first trial, or bringing in a new team to run one, you have probably heard people throw around terms like “Phase II” or “Phase III” in meetings. It can feel like everyone else already knows what this mean, and you are the only one guessing. In this blog, we have broken down clinical […]
Managing a clinical trial means balancing timelines, teams, budgets, data quality, and regulatory requirements at the same time. Effective clinical trial project management brings these moving parts together, helping study teams identify risks early, maintain compliance, and keep trials progressing smoothly from start-up through close-out. Why It Matters and How to Keep Teams, Timelines, and […]
Getting a new drug, biologic, or medical device to market is not a quick process. One of the biggest questions sponsors ask is simple: how long will this take? The answer depends on many factors, but understanding the key milestones can help you plan better and avoid surprises. In this blog, we have broken down what happens […]
Digital biomarkers are emerging as one of the most promising innovations in clinical research, offering a smarter and more objective way to monitor patient health. Unlike traditional biomarkers that rely on laboratory tests or occasional clinical assessments, digital biomarkers are generated through data collected by wearable devices, smartphones, mobile applications, and connected sensors. These technologies continuously capture health-related information such […]
Rare disease drug development runs on thin margins. Patient populations are small. Since patient populations are limited, high-quality biospecimen collection services become critical for generating reliable clinical evidence. Trial data is limited. Every page of every submission has to work harder to make the case for approval. This is where medical writing services play a role that goes far beyond simply putting […]
